News

SLOOSH® Introduces Affordable Paddle Boards for Everyone

SLOOSH® Introduces Affordable Paddle Boards for Everyone

SLOOSH® Unveils Stylish Inflatable Paddle Boards

Adventure on the water just received an exciting update with the launch of SLOOSH®, a brand recognized for transforming water activities into delightful experiences. Their new collection of inflatable paddle boards has been designed specifically for adults seeking enjoyment on the water without the hefty price tag. These boards are perfect for those who wish to disconnect and embrace unforgettable moments on the water.

Redefining Paddle Board Experiences

Replacing traditional, cumbersome paddle boards, SLOOSH® offers lightweight and easily portable options ideal for every enthusiast, regardless of skill level. Whether you are looking for a peaceful morning paddle or a fun-filled day at the lake with friends, SLOOSH® provides a range of boards catering to diverse needs and preferences.

Discover Three Unique Paddle Board Series

Each paddle board in SLOOSH®'s lineup is purposefully crafted for different types of adventurers. The collection includes the Ripple™, Meander™, and Rapids™ Series—each bringing its distinct features and benefits.

Ripple™ Series

This series emphasizes stability and style, equipped with an extra-wide base for enhanced balance. It’s the ideal choice for beginners and yoga practitioners who prefer a steady, calming experience on the water.

Meander™ Series

The perfect all-around companion for varied adventures, this series includes built-in mounts for your GoPro or fishing equipment, enhancing versatility. It is designed for intermediate paddlers who desire both speed and stability.

Rapids™ Series

For those who thrive on excitement and longer excursions, the Rapids™ Series promises top-tier performance. It combines speed and control, ensuring every paddler can tackle new challenges on their aquatic journey.

Every SLOOSH® paddle board is packaged with a matching set of accessories, ensuring you don’t just look good while paddling, but also have the best tools for a great time. With over 1,000 satisfied users, SLOOSH® is quickly becoming the preferred brand for casual adventurers and lifestyle enthusiasts alike.

Customer-Centric Philosophy

The head product designer at SLOOSH® notes, "We identified a gap in the market where most paddle boards seem overly sporty for everyday casual use, so we focused on aesthetics that appeal to a broader audience. Our mission is to provide stylish boards that perform exceptionally, ensuring relaxation and exploration is effortless and enjoyable."

Launch Celebration and Promotions

As part of the launch, SLOOSH® is inviting customers to enjoy a special promotional offer of up to 15% off with the early bird code SLOOSHSUP. This offer applies to select purchases on popular online platforms.”

To engage with the community, SLOOSH® is also hosting a giveaway for a free Ripple™ SUP valued at $299.99. Interested participants can enter by following SLOOSH® on social media and engaging with the promotional post. The winner will be drawn soon after the promotion period ends.

About SLOOSH®

The philosophy at SLOOSH® is about readily creating your paradise, regardless of the location—be it a local lake or your backyard. Since its inception in 2019, SLOOSH® has offered numerous ways to enjoy leisure and fun in the sun, crafting high-quality yet affordable products, including inflatable paddle boards and floats. Their mission is to spread joy and good vibes to everyone who craves adventure on the water.

Frequently Asked Questions

What types of paddle boards does SLOOSH® offer?

SLOOSH® provides three series of paddle boards: Ripple™, Meander™, and Rapids™, each tailored for distinct user preferences and experiences.

How can I avail of discounts on SLOOSH® products?

During the promotional period, you can use the code SLOOSHSUP for up to 15% off select products on major online retailers.

Where can I enter the SUP giveaway?

To enter the giveaway for a free Ripple™ SUP, follow SLOOSH® on social media and interact with their launch post to submit your entry.

What makes SLOOSH® paddle boards unique?

SLOOSH® paddle boards combine stylish designs with practical performance features, making them suitable for both experienced paddlers and newcomers.

What accessories come with the paddle boards?

Every SLOOSH® paddle board purchase includes a fully matched set of accessories to enhance your paddle boarding experience.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Expanding Horizons: Future of IVD Contract Manufacturing

Updated Category News Views 117

The Growing Landscape of IVD Contract Manufacturing The in vitro diagnostics (IVD) contract manufacturing market is on the brink of significant expansion, anticipated to reach a staggering USD 39.74 billion by 2031. This growth represents a compounded annual growth rate (CAGR) of 11.60% from 2024 to 2031, driven chiefly by the needs of the healthcare industry to keep pace...

Continue Reading
Citi Upgrades AerCap Holdings Price Target to $117 Amid Strong Performance

Updated Category News Views 79

Citi Upgrades AerCap Holdings Price Target Citi has recently updated its outlook on AerCap Holdings (NYSE:AER), raising the price target to $117 from $113. This move reflects Citi's confident stance on the aircraft leasing company's financial health within the aviation sector. By reaffirming their buy rating, the firm signals strong expectations for AerCap's growth...

Continue Reading
LG Energy Solution Reports Strong Q2 2025 Financial Performance

Updated Category News Views 750

LG Energy Solution Achieves Remarkable Financial Milestones In a significant announcement, LG Energy Solution has revealed its performance for the second quarter of 2025, detailing impressive results that demonstrate the company's resilience and strategic focus on growth. With consolidated revenue of KRW 5.6 trillion and an operating profit of KRW 492.2 billion, the...

Continue Reading
Genpact Shines as a Leader in Sustainability Recognition

Updated Category News Views 264

Genpact's Sustainable Initiatives Gain Global Recognition Recently, Genpact (NYSE: G), an advanced technology services provider, received significant acclaim for its commitment to sustainability. Being featured in TIME's prestigious list of the World's Best Companies in Sustainable Growth for 2025 showcases their dedication to ethical business practices and innovation. A...

Continue Reading
Medical Express Ambulance Faces Data Breach Investigation

Updated Category News Views 344

Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....

Continue Reading